Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - A single center experience

Jan C. Peeken, Christoph Knie, Kerstin A. Kessel, Daniel Habermehl, Severin Kampfer, Hendrik Dapper, Michal Devecka, Rüdiger Von Eisenhart-Rothe, Katja Specht, Wilko Weichert, Klaus Wörtler, Carolin Knebel, Jan J. Wilkens, Stephanie E. Combs

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Background: Advanced radiotherapy (RT) techniques allow normal tissue to be spared in patients with extremity soft tissue sarcoma (STS). This work aims to evaluate toxicity and outcome after neoadjuvant image-guided radiotherapy (IGRT) as helical intensity modulated radiotherapy (IMRT) with reduced margins based on MRI-based target definition in patients with STS. Methods: Between 2010 to 2014, 41 patients with extremity STS were treated with IGRT delivered as helical IMRT on a tomotherapy machine. The tumor site was in the upper extremity in 6 patients (15%) and lower extremity in 35 patients (85%). Reduced margins of 2.5 cm in longitudinal direction and 1.0 cm in axial direction were used to expand the MRI-defined gross tumor volume, including peritumoral edema, to the clinical target volume. An additional margin of 5 mm was added to receive the planning target volume. The full total dose of 50 Gy in 2 Gy fractions was sucessfully applied in 40 patients. Two patients received chemotherapy instead of surgery due to systemic progression. All patients were included into a strict follow-up program and were seen interdisciplinarily by the Departments of Orthopaedic Surgery and Radiation Oncology. Results: Thirty eight patients that received total RT total dose and subsequent resection were analyzed for outcome. After a median follow-up of 38.5 months cumulative OS, local PFS and systemic PFS at 2 years were determined at 78.2, 85.2 and 54.5%, respectively. Two of 6 local recurrences were proximal marginal misses. Negative resection margins were achieved in 84% of patients. The rate of major wound complications was comparable to previous IMRT studies with 36.8%. RT was overall tolerable with low toxicity rates. Conclusions: IMRT-IGRT offers neoadjuvant treatment for extremity STS with reduced safety margins and thus low toxicity rates. Wound complication rates were comparable to previously reported frequencies. Two reported marginal misses suggest a word of caution for reduction of longitudinal safety margins.

Original languageEnglish
Article number2
JournalRadiation Oncology
Volume14
Issue number1
DOIs
StatePublished - 9 Jan 2019

Keywords

  • Extremity
  • IGRT
  • IMRT
  • Image-guidance
  • Soft tissue sarcoma
  • Tomotherapy

Fingerprint

Dive into the research topics of 'Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - A single center experience'. Together they form a unique fingerprint.

Cite this